Other Liabilities - Epizyme Inc (F:EPE) - Alpha Spread
E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Epizyme Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epizyme Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
E
Epizyme Inc
F:EPE
Other Liabilities
$16.6m
CAGR 3-Years
12%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.4B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$2.2B
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$4.6B
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.5B
CAGR 3-Years
30%
CAGR 5-Years
57%
CAGR 10-Years
37%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.7B
CAGR 3-Years
37%
CAGR 5-Years
11%
CAGR 10-Years
23%

See Also

What is Epizyme Inc's Other Liabilities?
Other Liabilities
16.6m USD

Based on the financial report for Jun 30, 2022, Epizyme Inc's Other Liabilities amounts to 16.6m USD.

What is Epizyme Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-11%

Over the last year, the Other Liabilities growth was 29%. The average annual Other Liabilities growth rates for Epizyme Inc have been 12% over the past three years , -11% over the past five years .

Back to Top